Sigma-1 receptor concentration in plasma of patients with late-life depression: A preliminary study

Hideyuki Shimizu, Minoru Takebayashi, Masayuki Tani, Hiroaki Tanaka, Bun Yamagata, Kenzo Kurosawa, Hiroki Yamada, Mitsugu Hachisu, Kazue Hisaoka-Nakashima, Mami Okada-Tsuchioka, Masaru Mimura, Akira Iwanami

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Recently, the sigma-1 receptor has been shown to play a significant role in the neural transmission of mood by regulating N-methyl-D-aspartate receptors. Additionally, the sigma-1 receptor has been reported to influence cognitive functions including learning and memory. In this study, we measured plasma sigma-1 receptor concentrations before and after antidepressant treatment in patients with late-life major depressive disorder (MDD) and explored whether changes in depressive status are related to sigma-1 receptor concentrations. Methods: The study participants were 12 subjects with late-life MDD diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. All of the participants were over 60 years old. Immediately prior to and 8 weeks after the start of treatment, sigma-1 receptor concentration and mental status, including depressive symptoms (Hamilton Depression Rating Scale; HAM-D), were measured. Treatment for depression was performed according to a developed algorithm based on the choice of treatments. We examined the association between changes in sigma-1 receptor concentration and HAM-D scores during antidepressant treatment. For the measurement of plasma sigma-1 receptor concentration, blood plasma samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blots were performed using a specific antibody that acts against the sigma-1 receptor, and the net densities of each band were quantified. Results: All participants showed improvement in depressive symptoms, which was indicated by a significant decrease in the HAM-D scores. The mean plasma sigma-1 receptor concentration also increased significantly following antidepressant treatment. However, no significant correlations were found between changes in plasma sigma-1 receptor concentration and changes in HAM-D scores. Conclusion: In this preliminary study, we demonstrated that the sigma-1 receptor concentration in plasma increases following antidepressant treatment in patients with late-life MDD. Further studies are warranted to confirm this finding with a larger number of patients.

Original languageEnglish
Pages (from-to)1867-1872
Number of pages6
JournalNeuropsychiatric Disease and Treatment
Volume9
DOIs
Publication statusPublished - 2013 Dec 6

Fingerprint

Depression
Antidepressive Agents
Major Depressive Disorder
Therapeutics
sigma-1 receptor
N-Methyl-D-Aspartate Receptors
Synaptic Transmission
Sodium Dodecyl Sulfate
Diagnostic and Statistical Manual of Mental Disorders
Cognition
Polyacrylamide Gel Electrophoresis
Western Blotting
Learning
Antibodies

Keywords

  • Antidepressant treatment
  • Depressive symptoms
  • Late-life depression
  • Sigma-1 receptor

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Sigma-1 receptor concentration in plasma of patients with late-life depression : A preliminary study. / Shimizu, Hideyuki; Takebayashi, Minoru; Tani, Masayuki; Tanaka, Hiroaki; Yamagata, Bun; Kurosawa, Kenzo; Yamada, Hiroki; Hachisu, Mitsugu; Hisaoka-Nakashima, Kazue; Okada-Tsuchioka, Mami; Mimura, Masaru; Iwanami, Akira.

In: Neuropsychiatric Disease and Treatment, Vol. 9, 06.12.2013, p. 1867-1872.

Research output: Contribution to journalArticle

Shimizu, H, Takebayashi, M, Tani, M, Tanaka, H, Yamagata, B, Kurosawa, K, Yamada, H, Hachisu, M, Hisaoka-Nakashima, K, Okada-Tsuchioka, M, Mimura, M & Iwanami, A 2013, 'Sigma-1 receptor concentration in plasma of patients with late-life depression: A preliminary study', Neuropsychiatric Disease and Treatment, vol. 9, pp. 1867-1872. https://doi.org/10.2147/NDT.S53386
Shimizu, Hideyuki ; Takebayashi, Minoru ; Tani, Masayuki ; Tanaka, Hiroaki ; Yamagata, Bun ; Kurosawa, Kenzo ; Yamada, Hiroki ; Hachisu, Mitsugu ; Hisaoka-Nakashima, Kazue ; Okada-Tsuchioka, Mami ; Mimura, Masaru ; Iwanami, Akira. / Sigma-1 receptor concentration in plasma of patients with late-life depression : A preliminary study. In: Neuropsychiatric Disease and Treatment. 2013 ; Vol. 9. pp. 1867-1872.
@article{c3366122d59a4160af674621f832a38e,
title = "Sigma-1 receptor concentration in plasma of patients with late-life depression: A preliminary study",
abstract = "Background: Recently, the sigma-1 receptor has been shown to play a significant role in the neural transmission of mood by regulating N-methyl-D-aspartate receptors. Additionally, the sigma-1 receptor has been reported to influence cognitive functions including learning and memory. In this study, we measured plasma sigma-1 receptor concentrations before and after antidepressant treatment in patients with late-life major depressive disorder (MDD) and explored whether changes in depressive status are related to sigma-1 receptor concentrations. Methods: The study participants were 12 subjects with late-life MDD diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. All of the participants were over 60 years old. Immediately prior to and 8 weeks after the start of treatment, sigma-1 receptor concentration and mental status, including depressive symptoms (Hamilton Depression Rating Scale; HAM-D), were measured. Treatment for depression was performed according to a developed algorithm based on the choice of treatments. We examined the association between changes in sigma-1 receptor concentration and HAM-D scores during antidepressant treatment. For the measurement of plasma sigma-1 receptor concentration, blood plasma samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blots were performed using a specific antibody that acts against the sigma-1 receptor, and the net densities of each band were quantified. Results: All participants showed improvement in depressive symptoms, which was indicated by a significant decrease in the HAM-D scores. The mean plasma sigma-1 receptor concentration also increased significantly following antidepressant treatment. However, no significant correlations were found between changes in plasma sigma-1 receptor concentration and changes in HAM-D scores. Conclusion: In this preliminary study, we demonstrated that the sigma-1 receptor concentration in plasma increases following antidepressant treatment in patients with late-life MDD. Further studies are warranted to confirm this finding with a larger number of patients.",
keywords = "Antidepressant treatment, Depressive symptoms, Late-life depression, Sigma-1 receptor",
author = "Hideyuki Shimizu and Minoru Takebayashi and Masayuki Tani and Hiroaki Tanaka and Bun Yamagata and Kenzo Kurosawa and Hiroki Yamada and Mitsugu Hachisu and Kazue Hisaoka-Nakashima and Mami Okada-Tsuchioka and Masaru Mimura and Akira Iwanami",
year = "2013",
month = "12",
day = "6",
doi = "10.2147/NDT.S53386",
language = "English",
volume = "9",
pages = "1867--1872",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Sigma-1 receptor concentration in plasma of patients with late-life depression

T2 - A preliminary study

AU - Shimizu, Hideyuki

AU - Takebayashi, Minoru

AU - Tani, Masayuki

AU - Tanaka, Hiroaki

AU - Yamagata, Bun

AU - Kurosawa, Kenzo

AU - Yamada, Hiroki

AU - Hachisu, Mitsugu

AU - Hisaoka-Nakashima, Kazue

AU - Okada-Tsuchioka, Mami

AU - Mimura, Masaru

AU - Iwanami, Akira

PY - 2013/12/6

Y1 - 2013/12/6

N2 - Background: Recently, the sigma-1 receptor has been shown to play a significant role in the neural transmission of mood by regulating N-methyl-D-aspartate receptors. Additionally, the sigma-1 receptor has been reported to influence cognitive functions including learning and memory. In this study, we measured plasma sigma-1 receptor concentrations before and after antidepressant treatment in patients with late-life major depressive disorder (MDD) and explored whether changes in depressive status are related to sigma-1 receptor concentrations. Methods: The study participants were 12 subjects with late-life MDD diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. All of the participants were over 60 years old. Immediately prior to and 8 weeks after the start of treatment, sigma-1 receptor concentration and mental status, including depressive symptoms (Hamilton Depression Rating Scale; HAM-D), were measured. Treatment for depression was performed according to a developed algorithm based on the choice of treatments. We examined the association between changes in sigma-1 receptor concentration and HAM-D scores during antidepressant treatment. For the measurement of plasma sigma-1 receptor concentration, blood plasma samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blots were performed using a specific antibody that acts against the sigma-1 receptor, and the net densities of each band were quantified. Results: All participants showed improvement in depressive symptoms, which was indicated by a significant decrease in the HAM-D scores. The mean plasma sigma-1 receptor concentration also increased significantly following antidepressant treatment. However, no significant correlations were found between changes in plasma sigma-1 receptor concentration and changes in HAM-D scores. Conclusion: In this preliminary study, we demonstrated that the sigma-1 receptor concentration in plasma increases following antidepressant treatment in patients with late-life MDD. Further studies are warranted to confirm this finding with a larger number of patients.

AB - Background: Recently, the sigma-1 receptor has been shown to play a significant role in the neural transmission of mood by regulating N-methyl-D-aspartate receptors. Additionally, the sigma-1 receptor has been reported to influence cognitive functions including learning and memory. In this study, we measured plasma sigma-1 receptor concentrations before and after antidepressant treatment in patients with late-life major depressive disorder (MDD) and explored whether changes in depressive status are related to sigma-1 receptor concentrations. Methods: The study participants were 12 subjects with late-life MDD diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. All of the participants were over 60 years old. Immediately prior to and 8 weeks after the start of treatment, sigma-1 receptor concentration and mental status, including depressive symptoms (Hamilton Depression Rating Scale; HAM-D), were measured. Treatment for depression was performed according to a developed algorithm based on the choice of treatments. We examined the association between changes in sigma-1 receptor concentration and HAM-D scores during antidepressant treatment. For the measurement of plasma sigma-1 receptor concentration, blood plasma samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blots were performed using a specific antibody that acts against the sigma-1 receptor, and the net densities of each band were quantified. Results: All participants showed improvement in depressive symptoms, which was indicated by a significant decrease in the HAM-D scores. The mean plasma sigma-1 receptor concentration also increased significantly following antidepressant treatment. However, no significant correlations were found between changes in plasma sigma-1 receptor concentration and changes in HAM-D scores. Conclusion: In this preliminary study, we demonstrated that the sigma-1 receptor concentration in plasma increases following antidepressant treatment in patients with late-life MDD. Further studies are warranted to confirm this finding with a larger number of patients.

KW - Antidepressant treatment

KW - Depressive symptoms

KW - Late-life depression

KW - Sigma-1 receptor

UR - http://www.scopus.com/inward/record.url?scp=84889561775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889561775&partnerID=8YFLogxK

U2 - 10.2147/NDT.S53386

DO - 10.2147/NDT.S53386

M3 - Article

AN - SCOPUS:84889561775

VL - 9

SP - 1867

EP - 1872

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -